Development of guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy

Asia-Pacific Journal of Clinical Oncology

Volumn 6, Issue 3, 2010, Pages 213-219

  Carrington, Christine ^a   Stone, Leanne ^b   Koczwara, Bogda ^c   Searle, Christina ^d  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b Sunshine Coast Hospital   (Australia)

^c FLINDERS MEDICAL CENTRE   (Australia)

^d AUSTIN HEALTH   (Australia)

Author keywords

Chemotherapy; Medication error; Nurse; Pharmacist; Prescription

Indexed keywords

ARTICLE; AUSTRALIA; CANCER CHEMOTHERAPY; CONSENSUS DEVELOPMENT; HUMAN; MOLECULARLY TARGETED THERAPY; NORMAL HUMAN; NURSE; PATIENT SAFETY; PHARMACIST; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; STANDARDIZATION;

ANTINEOPLASTIC AGENTS; AUSTRALIA; EVIDENCE-BASED MEDICINE; HUMANS; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC;

EID: 77956292063     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/j.1743-7563.2010.01313.x     Document Type: Article

References (23)

1. Conway J, Nathan D, Benz E. Key learning from the Dana-Farber Cancer Institute's 10-year patient safety journey. 2004, Am Soc Clin Oncol Ed Book, 42nd Annual Meeting Atlanta, USA
2. Criteria for facilities and personnel for the administration of parenteral systemic antineoplastic therapy. Adopted on March 3, 2004 by the American Society of Clinical Oncology. J Clin Oncol 2004, 22:4613-15. American Society of Clinical Oncology
3. ASHP guidelines on preventing medication errors with antineoplastic agents. Am J Health Syst Pharm 2002, 59:1648-68. American Society of Health System Pharmacists
4. Smith J. Report of the Chief Pharmaceutical Officer Department of Health. Building a safer NHS for patients: sub section cytotoxic chemotherapy. 2003, http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4071443, Improving Medication Safety (38840, Citied 1 December 2009. Available from URL:
5. Womer RB, Tracy E, Soo-Hoo W, Bickert B, DiTaranto S, Barnsteiner JH. Multidisciplinary systems approach to chemotherapy safety: rebuilding processes and holding the gains. J Clin Oncol 2002, 20:4705-12.
6. Goldspiel BR, DeChristoforo R, Daniels CE. A continuous-improvement approach for reducing the number of chemotherapy-related medication errors. Am J Health Syst Pharm 2000, 57(4):S4-9. Suppl.
7. Gandhi TK, Bartel SB, Shulman LN. Medication safety in the ambulatory chemotherapy setting. Cancer 2005, 104:2477-83.
8. Schulmeister L. Preventing chemotherapy errors. Oncologist 2006, 11:463-8.
9. Dyer C. Doctor suspended after injecting wrong drug into spine. BMJ 2001, 322:257.
10. Vowels M. Review of Etoposide Phosphate Dosing in the Oncology Unit. 2008, http://www.wch.sa.gov.au/media/releases/documents/review_etoposide_dose.pdf, Cited 20 Dec 2009. Available from URL:
11. Etoposide Phosphate Update. 2008, http://www.publications.health.sa.gov.au/cgi/viewcontent.cgi?article=1090&context=dhm, Government of South Australia, Cited 20 Dec 2009. Available from URL: http://www.publications.health.sa.gov.au/cgi/viewcontent.cgi?article=1090&context=dhm
12. High risk medication alert - vincristine. http://www.safetyandquality.gov.au/internet/safety/publishing.nsf/Content/vincristine, Former Australian Council for Safety and Quality in Health Care, December 2005. Cited 1 Dec 2009. Available from URL:
13. Fluorouracil error ends tragically, but application of lessons learned will save lives. http://www.ismp.org/newsletters/acutecare/articles/20070920.asp, The Institute for Safe Medication Practice, ISMP Safety Alert. 2007; 12 Cited 1 Dec 2009. Available from URL:
14. Carrington C, Stone L, Koczwara B. The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapy. Asia-Pac J Clin Onco 2010, doi:10.1111/j.1743-7563.2010.01321.x (epub ahead of print)
15. Jacobson JO, Polovich M, McNiff KK. American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards. J Clin Oncol 2009, 27:5469-75.
16. Zaragoza MR, Ritchey ML, Walter A. Neurourologic consequences of accidental intrathecal vincristine: a case report. Med Pediatr Oncol 1995, 24:61-2.
17. Lowdown on lomustine: we'd hate CeeNU make this mistake. http://www.ismp.org/Newsletters/acutecare/articles/20040715.asp, The Institute for Safe Medication Practices, ISMP Safety Alert. 2004; July 15. Cited 1 Dec 2009. Available from URL:
18. Cohen MR. Hazard warning - vincristine overdose. Hosp Pharm 1994, 29:53.
19. Leape LL, Bates DW, Cullen DJ. Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA 1995, 274:35-43.
20. Bonnabry P, Cingria L, Ackermann M, Sadeghipour F, Bigler L, Mach N. Use of a prospective risk analysis method to improve the safety of the cancer chemotherapy process. Int J Qual Health Care 2006, 18:9-16.
21. Kozakiewicz JM, Benis LJ, Fisher SM, Marseglia JB. Safe chemotherapy administration: using failure mode and effects analysis in computerized prescriber order entry. Am J Health Syst Pharm 2005, 62:1813-16.
22. Mort D, Lansdown M, Smith N, Protopapa K, Mason M. For better, for worse? A review of the care of patients who died within 30 days of receiving systemic anti-cancer therapy. National Confidential Enquiry into Patient Outcome and Death. http://www.ncepod.org.uk/2008sact.htm, November 2009. Cited 1 Dec 2009. Available from URL:
23. Bates DW, Teich JM, Lee J. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999, 6:313-21.